Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's Disease
This article discusses the role that melatonin may have in the prevention and treatment of Parkinson's disease (PD). In parkinsonian patients circulating melatonin levels are consistently disrupted and the potential therapeutic value of melatonin on sleep disorders in PD was examined in a limit...
Saved in:
Main Authors: | Santiago Pérez-Lloret (Author), Daniel P. Cardinali (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Neuroprotection and disease modification in Parkinson's disease: Volume II
by: Matilde Otero-Losada, et al.
Published: (2023) -
Editorial: Neuroprotection and Disease Modification in Parkinson's Disease
by: Matilde Otero-Losada, et al.
Published: (2021) -
Dual-Task Treadmill Training for the Prevention of Falls in Parkinson's Disease: Rationale and Study Design
by: Veit Mylius, et al.
Published: (2022) -
Cytoprotective Effects of Melatonin Against Amitriptyline-Induced Toxicity in Isolated Rat Hepatocytes
by: Shohreh Taziki, et al.
Published: (2015) -
Melatonin Therapy in Patients with Alzheimer's Disease
by: Daniel P. Cardinali, et al.
Published: (2014)